4.6 Review

Tumor Budding as a Marker for Poor Prognosis and Epithelial-Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Tumor Budding in Gynecologic Cancer as a Marker for Poor Survival: A Systematic Review and Meta-Analysis of the Perspectives of Epithelial-Mesenchymal Transition

Muhammad Joan Ailia et al.

Summary: This study investigated the role of tumor budding (TB) in gynecological cancers and found that TB is associated with poor survival outcomes. TB is related to epithelial-mesenchymal transition, microvessel density, and decreased hormone receptor expression. TB can be used as a poor prognostic marker for gynecologic cancers.

CANCERS (2022)

Review Oncology

Tumour budding in solid cancers

Alessandro Lugli et al.

Summary: Tumour budding serves as an emerging prognostic biomarker in colorectal cancer and other solid cancers, with its predictive accuracy being widely supported by evidence. The standardized scoring system agreed upon at the International Tumour Budding Consensus Conference allows for an independent prediction of pathological features and unfavorable survival outcomes in patients.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Oncology

High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis

Nishant Thakur et al.

Summary: Poly (ADP-ribose) polymerase (PARP) is a DNA damage repair protein, and its inhibitors have shown promising results in clinical trials. The prognostic significance of PARP is inconsistent in studies of various cancers, but higher PARP expression is associated with worse overall survival, disease-free survival, and progression-free survival in patients with solid cancers.

CANCERS (2021)

Article Oncology

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer

Julia Judd et al.

Summary: The study characterized the genomic landscapes of KRAS-mutated non-small cell lung cancer in a large national cohort, revealing that different KRAS mutation subtypes have distinct co-occurring mutations and genomic landscapes.

MOLECULAR CANCER THERAPEUTICS (2021)

Article Oncology

Modified Tumor Budding as a Better Predictor of Lymph Node Metastasis in Early Gastric Cancer: Possible Real-World Applications

Kwangil Yim et al.

Summary: The study demonstrates that modified tumor budding (mTB) is a more accurate predictor of lymph node metastasis (LNM) in early gastric cancer patients compared to conventional tumor budding (TB). It enhances the predictive power of LNM, providing important information for patient treatment.

CANCERS (2021)

Article Oncology

DeepRePath: Identifying the Prognostic Features of Early-Stage Lung Adenocarcinoma Using Multi-Scale Pathology Images and Deep Convolutional Neural Networks

Won Sang Shim et al.

Summary: The study developed a DeepRePath model based on deep learning and multi-scale pathology images to predict recurrence in early-stage lung adenocarcinoma patients. The model demonstrated associations between atypical nuclei, discohesive tumor cells, and tumor necrosis in pathology images showing recurrence. Despite limitations, the model showed potential for predicting recurrence after curative resection of early-stage lung adenocarcinoma.

CANCERS (2021)

Article Medicine, General & Internal

Tumor budding in tumor tissue among operatively treated patients with lung adenocarcinoma

Milena Vasilijevic et al.

Summary: This study evaluated the clinicopathological significance of tumor budding in adenocarcinoma of the lung, finding a strong association with tumor size, nodal status, and pathological stage. Tumor budding was identified as an adverse prognostic factor, suggesting its potential inclusion in the staging system for lung adenocarcinoma.

VOJNOSANITETSKI PREGLED (2021)

Article Pathology

Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma

Ekaterina Petrova et al.

VIRCHOWS ARCHIV (2020)

Review Oncology

Tumour budding and its clinical implications in gastrointestinal cancers

Inti Zlobec et al.

BRITISH JOURNAL OF CANCER (2020)

Review Medicine, General & Internal

Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Narjust Duma et al.

MAYO CLINIC PROCEEDINGS (2019)

Review Oncology

RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer

Valeria Maffeis et al.

FRONTIERS IN ONCOLOGY (2019)

Article Medicine, General & Internal

Introducing RAPTOR: RevMan Parsing Tool for Reviewers

Lena Schmidt et al.

SYSTEMATIC REVIEWS (2019)

Article Cell Biology

Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system

Eva Karamitopoulou et al.

HISTOPATHOLOGY (2018)

Review Oncology

EMT in cancer

Thomas Brabletz et al.

NATURE REVIEWS CANCER (2018)

Article Respiratory System

Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma

Wilko Weichert et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Review Medicine, General & Internal

Effect of Cigarette Smoking on Epithelial to Mesenchymal Transition (EMT) in Lung Cancer

Trung Vu et al.

JOURNAL OF CLINICAL MEDICINE (2016)

Review Medicine, General & Internal

Tumor Budding: The Name is EMT. Partial EMT.

Alexandru Dan Grigore et al.

JOURNAL OF CLINICAL MEDICINE (2016)

Review Oncology

Lung cancer epidemiology: contemporary and future challenges worldwide

Joanna Didkowska et al.

ANNALS OF TRANSLATIONAL MEDICINE (2016)

Article Physiology

Nicotine-induced epithelial-mesenchymal transition via Wnt/β-catenin signaling in human airway epithelial cells

Weifeng Zou et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)